No groundbreaking research in those skin conditions that you mention (you may want to take a look at BOT for that) and therefore none of the huge expenses associated with "groundbreaking" research; what's making BDA stands apart is actually their capacity for generating revenues immediately and having a nicely set plan to growth.
Quarterly shall be out soon and BDA's value may appear clearer then.
